Laboratory of Chemical Biology, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.
Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.
Nat Commun. 2021 Jul 28;12(1):4586. doi: 10.1038/s41467-021-24874-3.
Heterogeneous immunoassays such as ELISA have become indispensable in modern bioanalysis, yet translation into point-of-care assays is hindered by their dependence on external calibration and multiple washing and incubation steps. Here, we introduce RAPPID (Ratiometric Plug-and-Play Immunodiagnostics), a mix-and-measure homogeneous immunoassay platform that combines highly specific antibody-based detection with a ratiometric bioluminescent readout. The concept entails analyte-induced complementation of split NanoLuc luciferase fragments, photoconjugated to an antibody sandwich pair via protein G adapters. Introduction of a calibrator luciferase provides a robust ratiometric signal that allows direct in-sample calibration and quantitative measurements in complex media such as blood plasma. We developed RAPPID sensors that allow low-picomolar detection of several protein biomarkers, anti-drug antibodies, therapeutic antibodies, and both SARS-CoV-2 spike protein and anti-SARS-CoV-2 antibodies. With its easy-to-implement standardized workflow, RAPPID provides an attractive, fast, and low-cost alternative to traditional immunoassays, in an academic setting, in clinical laboratories, and for point-of-care applications.
异质免疫分析,如 ELISA,已成为现代生物分析中不可或缺的手段,但由于其依赖外部校准以及多次洗涤和孵育步骤,将其转化为即时检测(point-of-care assay)仍然存在阻碍。在这里,我们介绍了 RAPPID(比率型即插即用免疫诊断),这是一种混合和测量的均相免疫分析平台,它将基于抗体的高特异性检测与比率型生物发光读数相结合。该概念需要通过蛋白 G 接头将分裂的 NanoLuc 荧光素酶片段与抗体夹心对进行光连接,以实现分析物诱导的互补。引入校准荧光素酶提供了一个稳健的比率信号,允许在复杂介质(如血浆)中直接进行样品内校准和定量测量。我们开发了 RAPPID 传感器,可实现对几种蛋白质生物标志物、抗体药物、治疗性抗体以及 SARS-CoV-2 刺突蛋白和抗 SARS-CoV-2 抗体的低皮摩尔检测。凭借其易于实施的标准化工作流程,RAPPID 为传统免疫分析提供了一种有吸引力、快速且低成本的替代方案,适用于学术环境、临床实验室以及即时检测应用。